自体脂肪间充质干细胞（MSCs）局部应用于持续性无菌性角膜上皮缺损。 - Suppr | 超能文献

相似文献

1

Topical application of autologous adipose-derived mesenchymal stem cells (MSCs) for persistent sterile corneal epithelial defect.自体脂肪间充质干细胞（MSCs）局部应用于持续性无菌性角膜上皮缺损。

Graefes Arch Clin Exp Ophthalmol. 2012 Mar;250(3):455-7. doi: 10.1007/s00417-011-1841-3. Epub 2011 Oct 20.

2

potential of human mesenchymal stem cells for corneal epithelial regeneration.人骨髓间充质干细胞在角膜上皮再生中的潜力。

Regen Med. 2020 Mar;15(3):1409-1426. doi: 10.2217/rme-2019-0067. Epub 2020 Apr 30.

3

Mesenchymal Stem Cells Promote Diabetic Corneal Epithelial Wound Healing Through TSG-6-Dependent Stem Cell Activation and Macrophage Switch.间充质干细胞通过TSG-6依赖的干细胞激活和巨噬细胞转换促进糖尿病角膜上皮伤口愈合。

Invest Ophthalmol Vis Sci. 2017 Aug 1;58(10):4344–4354. doi: 10.1167/iovs.17-21506.

4

In vitro simulation of corneal epithelium microenvironment induces a corneal epithelial-like cell phenotype from human adipose tissue mesenchymal stem cells.体外模拟角膜上皮微环境诱导人脂肪组织间充质干细胞向角膜上皮样细胞表型分化。

Curr Eye Res. 2013 Sep;38(9):933-44. doi: 10.3109/02713683.2013.802809. Epub 2013 Jun 14.

5

Treatment of persistent corneal epithelial defect with overnight wear of a prosthetic device for the ocular surface.使用眼表面修复体过夜佩戴治疗持续性角膜上皮缺损。

Am J Ophthalmol. 2013 Dec;156(6):1095-101. doi: 10.1016/j.ajo.2013.06.006. Epub 2013 Sep 25.

6

[Autologous serum for otherwise therapy resistant corneal epithelial defects - Prospective report on the first 70 eyes].[自体血清治疗其他方法难以治愈的角膜上皮缺损——70例首诊患者的前瞻性报告]

Klin Monbl Augenheilkd. 2001 Nov;218(11):720-6. doi: 10.1055/s-2001-18663.

7

Rapid healing of a persistent corneal epithelial defect (PCED) with autologous serum treatment.自体血清治疗使持续性角膜上皮缺损（PCED）快速愈合。

Niger J Clin Pract. 2020 Jan;23(1):123-125. doi: 10.4103/njcp.njcp_172_19.

8

Clinical outcomes of xeno-free expansion and transplantation of autologous ocular surface epithelial stem cells via contact lens delivery: a prospective case series.通过隐形眼镜递送进行无动物源自体眼表上皮干细胞的扩增和移植的临床结果：一项前瞻性病例系列研究

Stem Cell Res Ther. 2015 Mar 12;6(1):23. doi: 10.1186/s13287-015-0009-1.

9

PROSE therapy used to minimize corneal trauma in patients with corneal epithelial defects.前节角膜上皮缺损患者应用 PROSE 治疗以减少角膜创伤。

Am J Ophthalmol. 2013 Apr;155(4):615-619, 619.e1-2. doi: 10.1016/j.ajo.2012.09.033. Epub 2012 Dec 4.

10

Reconstruction of chemically burned rat corneal surface by bone marrow-derived human mesenchymal stem cells.骨髓来源的人间充质干细胞对化学烧伤大鼠角膜表面的重建

Stem Cells. 2006 Feb;24(2):315-21. doi: 10.1634/stemcells.2005-0046. Epub 2005 Aug 18.

引用本文的文献

1

Molecular and Cellular Mechanisms of the Therapeutic Effect of Mesenchymal Stem Cells and Extracellular Vesicles in Corneal Regeneration.间质干细胞和细胞外囊泡在角膜再生治疗效果的分子和细胞机制。

Int J Mol Sci. 2024 Oct 16;25(20):11121. doi: 10.3390/ijms252011121.

2

Unlocking the versatile potential: Adipose-derived mesenchymal stem cells in ocular surface reconstruction and oculoplastics.释放多功能潜力：脂肪来源的间充质干细胞在眼表重建和眼部整形中的应用

World J Stem Cells. 2024 Feb 26;16(2):89-101. doi: 10.4252/wjsc.v16.i2.89.

3

Extracellular-Vesicle-Based Therapeutics in Neuro-Ophthalmic Disorders.

本文引用的文献

1

Mechanisms involved in the therapeutic properties of mesenchymal stem cells.间充质干细胞治疗特性涉及的机制。

Cytokine Growth Factor Rev. 2009 Oct-Dec;20(5-6):419-27. doi: 10.1016/j.cytogfr.2009.10.002. Epub 2009 Nov 18.

2

Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.脂肪细胞作为免疫细胞：在正常和病理性脂肪组织发育的不同阶段，肿瘤坏死因子样弱凋亡诱导因子（TWEAK）、B细胞活化因子（BAFF）和增殖诱导配体（APRIL）及其受体（Fn14、BAFF-R、跨膜激活剂和钙调亲环素配体相互作用分子（TACI）以及B细胞成熟抗原（BCMA））的差异表达

J Immunol. 2009 Nov 1;183(9):5948-56. doi: 10.4049/jimmunol.0901186. Epub 2009 Oct 14.

3